PPIDT00419
Drug Information
| Name | Somapacitan |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB15093 |
| Type | biotech |
| Indication | Somapacitan is indicated as a replacement for growth hormone in adult patients with growth hormone deficiency.[L15661] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
10 mg/1mL
|
| Injection, solution | Subcutaneous |
10 MG/1.5ML
|
| Injection, solution | Subcutaneous |
15 mg/1.5ml
|
| Injection, solution | Subcutaneous |
3.3 mg/1mL
|
| Injection, solution | Subcutaneous |
5 mg/1.5ml
|
| Injection, solution | Subcutaneous |
6.7 mg/1mL
|
| Solution | Subcutaneous |
10 mg / 1.5 mL
|
| Solution | Subcutaneous |
15 mg / 1.5 mL
|
| Solution | Subcutaneous |
3.30 mg
|
| Solution | Subcutaneous |
5 mg / 1.5 mL
|
| Solution | Subcutaneous |
1000000 mg
|
| Solution | Subcutaneous |
500000 mg
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P10912 | GHR | Growth hormone receptor | Homo sapiens | agonist | Link |
| enzyme | P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Homo sapiens | inhibitor | Link |
| enzyme | P11510 | Cyp2c12 | Cytochrome P450 2C12, female-specific | Rattus norvegicus | inducer | Link |
| enzyme | P05177 | CYP1A2 | Cytochrome P450 1A2 | Homo sapiens | inducer | Link |
| enzyme | P33261 | CYP2C19 | Cytochrome P450 2C19 | Homo sapiens | inhibitor | Link |
| carrier | P02768 | ALB | Albumin | Homo sapiens | binder | Link |